Investment Summary

TPG Invests In ChemEOR

On June 1, 2013, private equity firm TPG invested in chemicals company ChemEOR

Investment Highlights
  • This is TPG’s 5th transaction in the Chemicals sector.
  • This is TPG’s 143rd transaction in the United States.
  • This is TPG’s 47th transaction in California.

Investment Summary

Date 2013-06-01
Target ChemEOR
Sector Chemicals
Investor(s) TPG
Deal Type Growth Capital

Target

ChemEOR

Covina , California, United States
ChemEOR is an innovative company focused on providing chemicals used in well stimulation and Enhanced Oil Recovery (EOR). ChemEOR was founded in 2005 and is based in Covina, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 210 of 451
Sector: Chemicals M&A 5 of 7
Type: Growth Capital M&A Deals 22 of 74
State: California M&A 47 of 88
Country: United States M&A 143 of 298
Year: 2013 M&A 12 of 26
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-01 VLST Corp

Seattle, Washington, United States

VLST Coporation, a biotechnology company, engages in the discovery and development of novel therapeutics for the treatment of inflammatory and autoimmune disorders. Its proprietary technology platform allows for the identification of validated drug targets based on a thorough understanding of virulence gene products and their function.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-03 HotSchedules

Austin, Texas, United States

HotSchedules provides state-of-the-art technology, services and user experiences for the restaurant, retail and hospitality verticals. Over 30,000 customers across 170,000+ locations globally – from large international chains to independent and emerging concepts – rely on HotSchedules’ software and solutions to help them control costs, maintain compliance, improve visibility, increase profitability and drive operational consistency. HotSchedules was founded in 1999 and is based in Austin, Texas.

Buy -